The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life
Background: Chemotherapy at the end of life is a complex and challenging problem in medical oncology. Patients affected by ovarian cancer (OC) often experience a chronicization and slow progression of their disease, and chemotherapy is proposed until the end of life.